Literature DB >> 17363582

The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.

Cheng Liu1, Xiaolei Fang, Zheng Ge, Marit Jalink, Satoru Kyo, Magnus Björkholm, Astrid Gruber, Jan Sjöberg, Dawei Xu.   

Abstract

Recent evidence has accumulated that the dynamic histone methylation mediated by histone methyltransferases and demethylases plays key roles in regulation of chromatin structure and transcription. In the present study, we show that SET and MYND domain-containing protein 3 (SMYD3), a histone methyltransferase implicated in oncogenesis, directly trans-activates the telomerase reverse transcriptase (hTERT) gene that is essential for cellular immortalization and transformation. SMYD3 occupies its binding motifs on the hTERT promoter and is required for maintenance of histone H3-K4 trimethylation, thereby contributing to inducible and constitutive hTERT expression in normal and malignant human cells. Knocking down SMYD3 in tumor cells abolished trimethylation of H3-K4, attenuated the occupancy by the trans-activators c-MYC and Sp1, and led to diminished histone H3 acetylation in the hTERT promoter region, which was coupled with down-regulation of hTERT mRNA and telomerase activity. These results suggest that SMYD3-mediated trimethylation of H3-K4 functions as a licensing element for subsequent transcription factor binding to the hTERT promoter. The present findings provide significant insights into regulatory mechanisms of hTERT/telomerase expression; moreover, identification of the hTERT gene as a direct target of SMYD3 contributes to a better understanding of SMYD3-mediated cellular transformation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363582     DOI: 10.1158/0008-5472.CAN-06-4126

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

Review 1.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

2.  Novel insights into the oncogenic function of the SMYD3 lysine methyltransferase.

Authors:  Pawel K Mazur; Or Gozani; Julien Sage; Nicolas Reynoird
Journal:  Transl Cancer Res       Date:  2016-06       Impact factor: 1.241

3.  SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells.

Authors:  Qing-Qing Dong; Qiu-Tong Wang; Lei Wang; Ya-Xin Jiang; Mei-Ling Liu; Hai-Jie Hu; Yong Liu; Hao Zhou; Hong-Peng He; Tong-Cun Zhang; Xue-Gang Luo
Journal:  Food Sci Biotechnol       Date:  2018-03-22       Impact factor: 2.391

Review 4.  Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene.

Authors:  Jiyue Zhu; Yuanjun Zhao; Shuwen Wang
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

5.  Changes in telomerase activity due to alternative splicing of human telomerase reverse transcriptase in colorectal cancer.

Authors:  Hei Cheul Jeung; Sun Young Rha; Sang Joon Shin; Joong Bae Ahn; Kyu Hyun Park; Tae Soo Kim; Jin Ju Kim; Jae Kyung Roh; Hyun Cheol Chung
Journal:  Oncol Lett       Date:  2017-06-21       Impact factor: 2.967

Review 6.  SET and MYND domain containing protein 3 in cancer.

Authors:  Lei Huang; A-Man Xu
Journal:  Am J Transl Res       Date:  2017-01-15       Impact factor: 4.060

7.  VHL-HIF-2α axis-induced SMYD3 upregulation drives renal cell carcinoma progression via direct trans-activation of EGFR.

Authors:  Cheng Liu; Li Liu; Kun Wang; Xiao-Feng Li; Li-Yuan Ge; Run-Zhuo Ma; Yi-Dong Fan; Lu-Chao Li; Zheng-Fang Liu; Min Qiu; Yi-Chang Hao; Zhen-Feng Shi; Chuan-You Xia; Klas Strååt; Yi Huang; Lu-Lin Ma; Dawei Xu
Journal:  Oncogene       Date:  2020-04-14       Impact factor: 9.867

Review 8.  Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

Authors:  Xuejiao Tian; Saiyang Zhang; Hong-Min Liu; Yan-Bing Zhang; Christopher A Blair; Dan Mercola; Paolo Sassone-Corsi; Xiaolin Zi
Journal:  Curr Cancer Drug Targets       Date:  2013-06       Impact factor: 3.428

Review 9.  Telomeres-structure, function, and regulation.

Authors:  Weisi Lu; Yi Zhang; Dan Liu; Zhou Songyang; Ma Wan
Journal:  Exp Cell Res       Date:  2012-09-21       Impact factor: 3.905

Review 10.  Non-duplex G-Quadruplex Structures Emerge as Mediators of Epigenetic Modifications.

Authors:  Ananda Kishore Mukherjee; Shalu Sharma; Shantanu Chowdhury
Journal:  Trends Genet       Date:  2018-12-04       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.